OS Therapies Incorporated
OSTX
$1.69
$0.031.81%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -148.55% | -121.18% | -52.64% | -14.00% | 17.15% |
| Total Depreciation and Amortization | 17,007.14% | 2,338.30% | -41.67% | -33.33% | -72.00% |
| Total Amortization of Deferred Charges | -100.00% | -85.17% | -29.78% | -46.13% | -46.42% |
| Total Other Non-Cash Items | -- | -- | -21.10% | 158.61% | -100.00% |
| Change in Net Operating Assets | 4,003.17% | -31.37% | -142.50% | -106.43% | -103.76% |
| Cash from Operations | -122.93% | -253.49% | -213.06% | -142.17% | -57.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -100.00% | -100.00% | -72.17% | -44.54% | -27.01% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 19.87% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 905.70% | 155.24% | 100.00% | 23.59% |
| Cash from Financing | 75.41% | 344.31% | 342.64% | 344.66% | 109.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.00% | 5,836.62% | 1,225.36% | 4,243.67% | 8,039.66% |